Lacidipine Generics [uk]

Lacidipine, the active ingredient in Lacidipine Generics, is a calcium channel blocker presented as a tablet for oral use. It is used to lower elevated blood pressure in adult patients with hypertension. GNH USA supplies Lacidipine Generics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacidipine is indicated for the management of hypertension, acting on the vascular smooth‑muscle calcium channels to reduce systemic vascular resistance.

Hypertension: helps achieve target blood pressure levels and reduces cardiovascular risk.

Lacidipine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or feet. - Dizziness or light‑headedness, especially on standing. - Nausea or abdominal discomfort. - Tachycardia: increased heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Angioedema: swelling of face, lips, tongue, or throat. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, pruritus, or anaphylaxis. - Myocardial infarction: rare but reported in susceptible individuals.

Before initiating Lacidipine therapy, consider the following safety measures.

Renal or hepatic impairment: dose may need adjustment and monitoring. - Concomitant antihypertensives: monitor for additive hypotensive effects. - History of angioedema: avoid use due to risk of recurrence. - Pregnancy and lactation: safety not established; use only if clearly needed. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Lacidipine can interact with several drug classes, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase Lacidipine plasma levels. - Grapefruit juice: can markedly raise drug concentration. - Concurrent use with other potent vasodilators: risk of severe hypotension.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Diuretics or beta‑blockers: may enhance blood‑pressure lowering effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may attenuate antihypertensive response.